In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The price of GSK Plc ADR (NYSE: GSK) closed at $36.75 in the last session, down -1.53% from day before closing price of $37.32. In other words, the price has decreased by -$1.53 from its previous closing price. On the day, 3.12 million shares were traded. GSK stock price reached its highest trading level at $37.38 during the session, while it also had its lowest trading level at $36.75.
Ratios:
We take a closer look at GSK’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 14.95 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 9.58. For the most recent quarter (mrq), Quick Ratio is recorded 0.57 and its Current Ratio is at 0.87. In the meantime, Its Debt-to-Equity ratio is 1.17 whereas as Long-Term Debt/Eq ratio is at 1.03.
On April 15, 2025, Exane BNP Paribas started tracking the stock assigning a Neutral rating and target price of $35.25.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 27 ’24 when GSK plc bought 2,791,930 shares for $8.00 per share. The transaction valued at 22,335,440 led to the insider holds 16,775,691 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GSK now has a Market Capitalization of 74985070592 and an Enterprise Value of 162025242624. As of this moment, GSK’s Price-to-Earnings (P/E) ratio for their current fiscal year is 17.13, and their Forward P/E ratio for the next fiscal year is 7.60. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.79. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.81 while its Price-to-Book (P/B) ratio in mrq is 3.67. Its current Enterprise Value per Revenue stands at 5.122 whereas that against EBITDA is 17.439.
Stock Price History:
The Beta on a monthly basis for GSK is 0.53, which has changed by -0.08170915 over the last 52 weeks, in comparison to a change of 0.19283521 over the same period for the S&P500. Over the past 52 weeks, GSK has reached a high of $44.67, while it has fallen to a 52-week low of $31.72. The 50-Day Moving Average of the stock is -5.48%, while the 200-Day Moving Average is calculated to be -0.47%.
Shares Statistics:
According to the various share statistics, GSK traded on average about 5.42M shares per day over the past 3-months and 4816550 shares per day over the past 10 days. A total of 2.02B shares are outstanding, with a floating share count of 2.02B. Insiders hold about 0.00% of the company’s shares, while institutions hold 18.42% stake in the company. Shares short for GSK as of 1752537600 were 13514900 with a Short Ratio of 2.49, compared to 1749772800 on 16477295. Therefore, it implies a Short% of Shares Outstanding of 13514900 and a Short% of Float of 0.67000003.
Dividends & Splits
The forward annual dividend rate for GSK is 1.61, which was 0.63 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.016881028The stock’s 5-year Average Dividend Yield is 4.75. The current Payout Ratio is 94.89% for GSK, which recently paid a dividend on 2025-05-16 with an ex-dividend date of 2025-08-15. Stock splits for the company last occurred on 2022-07-22 when the company split stock in a 1226:1000 ratio.
